Abstract

BackgroundNeuroinflammation plays an important role in the pathogenesis of glaucoma. Tumor necrosis factor-alpha (TNF-α) is a major pro-inflammatory cytokine released from activated retinal glial cells in glaucoma. Here, we investigated how TNF-α induces retinal ganglion cell (RGC) hyperexcitability and injury.MethodsWhole-cell patch-clamp techniques were performed to explore changes in spontaneous firing and evoked action potentials, and Na+ currents in RGCs. Both intravitreal injection of TNF-α and chronic ocular hypertension (COH) models were used. Western blotting, immunofluorescence, quantitative real-time polymerase chain reaction (q-PCR), and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) techniques were employed to investigate the molecular mechanisms of TNF-α effects on RGCs.ResultsIntravitreal injection of soluble TNF-α significantly increased the spontaneous firing frequencies of RGCs in retinal slices. When the synaptic transmissions were blocked, more than 90% of RGCs still showed spontaneous firing; both the percentage of cells and firing frequency were higher than the controls. Furthermore, the frequency of evoked action potentials was also higher than the controls. Co-injection of the TNF-α receptor 1 (TNFR1) inhibitor R7050 eliminated the TNF-α-induced effects, suggesting that TNF-α may directly act on RGCs to induce cell hyperexcitability through activating TNFR1. In RGCs acutely isolated from TNF-α-injected retinas, Na+ current densities were upregulated. Perfusing TNF-α in RGCs of normal rats mimicked this effect, and the activation curve of Na+ currents shifted toward hyperpolarization direction, which was mediated through p38 MAPK and STAT3 signaling pathways. Further analysis revealed that TNF-α selectively upregulated Nav1.6 subtype of Na+ currents in RGCs. Similar to observations in retinas of rats with COH, intravitreal injection of TNF-α upregulated the expression of Nav1.6 proteins in both total cell and membrane components, which was reversed by the NF-κB inhibitor BAY 11-7082. Inhibition of TNFR1 blocked TNF-α-induced RGC apoptosis.ConclusionsTNF-α/TNFR1 signaling induces RGC hyperexcitability by selectively upregulating Nav1.6 Na+ channels, thus contributing to RGC apoptosis in glaucoma.

Highlights

  • Glaucoma, the leading cause of irreversible blindness, is a retinal neurodegenerative disease, which affects over 60 million people around the world [1,2,3]

  • Perfusing Tumor necrosis factoralpha (TNF-α) in retinal ganglion cells (RGCs) of normal rats mimicked this effect, and the activation curve of Na+ currents shifted toward hyperpolarization direction, which was mediated through p38 MAPK and signal transducer and activator of transcription 3 (STAT3) signaling pathways

  • Since Intraocular pressure (IOP) elevation-induced hyperexcitability of RGCs in chronic ocular hypertension (COH) retinas could be reversed by TNF-α and nitric oxide (NO) blockers [28], we first examined whether TNF-α could induce RGC hyperexcitability in normal rats

Read more

Summary

Introduction

The leading cause of irreversible blindness, is a retinal neurodegenerative disease, which affects over 60 million people around the world [1,2,3]. Progressive apoptotic death of retinal ganglion cells (RGCs) and degeneration of RGC axons and dendrites, resulting in visual field loss, are the fundamental pathogenesis of glaucoma [4,5,6,7,8]. Increasing evidence indicates that neuroinflammation induced by excessive proinflammatory factors, which are released from activated retinal glial cells, plays significant roles in RGC damage in glaucoma [13,14,15]. TNF-α plays important roles in the pathogenesis of retinal diseases, such as glaucoma. TNF-α-induced RGC death in glaucoma could be mediated by multiple pathways. Neuroinflammation plays an important role in the pathogenesis of glaucoma. Tumor necrosis factoralpha (TNF-α) is a major pro-inflammatory cytokine released from activated retinal glial cells in glaucoma. We investigated how TNF-α induces retinal ganglion cell (RGC) hyperexcitability and injury

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.